Sequans Communications (SQNS) delivered a third-quarter beat that is cleaner operationally than its accounting history might suggest. The company reported a loss of $0.07 per share against a consensus estimate of -$0.58, an 87.9% earnings surprise. Earnings improved 91.7% from a year ago. Revenue of $9.09 million topped the $8.97 million consensus by 1.3% and grew 111.9% year over year on Earnings Whispers' normalized basis. The company's own figure is 182.8%, measured against a restated $3.2 million in the year-ago quarter, so the growth rate depends on the comparison base. Either way, the trajectory is clear. Revenue has climbed from $6.1 million in Q1 to $7.5 million in Q2 and $9.1 million in Q3, and product sales more than quadrupled from a year ago, up from roughly a doubling in Q2. The central tension is that the semiconductor business is finally scaling, yet nearly every profitability milestone management set at the start of the year has slipped.

The quality of the bottom line deserves scrutiny. The headline loss also differs across measures: IFRS diluted loss was $0.10 per ADS and non-IFRS loss was $0.04, compared with $0.65 and $0.27 in Q2. Much of the sequential improvement reflects the end of Bitcoin-related noise. Q3 carried no impairment charge and far lower non-cash convertible interest. The operating loss narrowed to $1.0 million from $7.2 million, but that figure includes a $6.2 million realized gain on Bitcoin sales. Without that one-time item, the operating loss would have been roughly $7.3 million. The genuine progress is in costs. Operating expenses fell to $10.3 million from $11.9 million in Q2, with R&D, sales and marketing, and G&A all declining, and management is targeting a roughly $10 million quarterly average in 2027. Quarterly cash burn dropped to $5.9 million from about $10 million in Q1.

The weak spot is gross margin, which is moving in the wrong direction for a company trying to scale toward profitability. Gross margin was 33.0% in Q3, essentially flat with 32.9% in Q2 but well below 37.7% in Q1 and 41.4% in Q4 of fiscal 2025. Management guided cautiously to a similar level in Q4, citing memory prices that are reset month to month. Relief from dual-sourcing flash memory does not arrive until 2027. A higher-margin licensing contribution would help, but it remains elusive. The Q2 call promised a meaningful increase in licensing in the second half, and the high end of the Q3 guide assumed a deal closed. None did, so Q3 revenue landed in the lower-middle of its $8.5-10 million range.

The forward-looking evidence is more encouraging, and management's tone was noticeably more confident now that the company is fully focused on semiconductors.

• **Q4 guidance:** Revenue guidance of $9.5-11 million steps up again and excludes major licensing deals.
• **Design wins:** Design wins in mass production are expected to exceed $180 million by year-end, up from $165 million at Q2 and $132 million at Q4 fiscal 2025. The company added nine new design wins in the quarter.
• **Backlog:** Backlog now extends into the second half of 2027, and book-to-bill has been above 1 for three straight quarters.
• **RF and drones:** The first drone RF customer begins shipping in Q4, earlier than the 'early next year' timing given previously. The RF and defense pipeline was quantified for the first time at more than $30 million of three-year revenue.
• **Licensing pipeline:** The licensing pipeline was quantified at more than $75 million.

The resets matter just as much. Full-year 2026 revenue is tracking around $32-34 million, against the $40-45 million plan outlined on the Q4 fiscal 2025 call. Cash-flow breakeven has drifted from Q4 2026 to 'close to breakeven' on a 2027 annual basis. Bears also have a new supply risk to point to: TSMC capacity allocation on mature nodes in 2027 could constrain silicon just as volumes are expected to ramp.

The balance sheet is the clearest change in the investment setup. Sequans holds no Bitcoin and no convertible debt. The release puts cash and short-term deposits at $39.7 million, while the call cited $39.1 million. In addition, a roughly $2.5 million French R&D grant was received in October. The overhang from a leveraged crypto treasury is gone, replaced by a straightforward fabless chip story.

The market had not been rewarding that transition heading into the report. Investor sentiment swung from a moderately positive 0.36 after the prior report to -0.15, a meaningful deterioration. Shares were at $2.48, down 8.5% since the open following the August report. That leaves the stock 21.7% below its 200-day moving average and 22% below the inter-earnings high of $3.18 set in early August. The stock set a 52-week low of $2.31 on October 19 and sits just 7.4% above it. The Earnings Whispers trend readings are mixed: sequential growth and momentum are positive, while price and AVWAP remain negative. That split mirrors the gap between improving operations and weak price action.

The bottom line is that Sequans delivered real operating progress this quarter. Product revenue is accelerating, costs are falling, guidance rose again, and the balance sheet is finally simple. Against that, gross margins have compressed, licensing keeps slipping, and both the 2026 revenue plan and the breakeven date have moved out. Investors entered the report skeptical and near the lows, so the burden now falls on Q4 execution, a signed licensing deal and stabilizing margins to show that the growth story can translate into profitability.